Evidence for the involvement of catecholamines in the 2-DG-induced immunomodulatory effects in spleen

Brain, Behavior, and Immunity

Volumn 11, Issue 2, 1997, Pages 79-93

  Chou, Shiu Huey ^a   Kojic, Ljiljana D ^a   Cunnick, Joan E ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; CORTICOSTERONE; DEOXYGLUCOSE; GAMMA INTERFERON; GLUCOSE; NADOLOL; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; IMMUNOMODULATION; LEUKOCYTE; LEUKOCYTE COUNT; MACROPHAGE; MALE; MITOGENESIS; NATURAL KILLER CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0031171043     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1997.0483     Document Type: Article

References (36)

1. Abrass, C. K., O'Connor, S. W., Scarpace, P. J., & Abrass, I. B. (1985). Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J. Immunol. 135, 1338-1341.
2. Antonaccio, M. J., & DeForrest, J. (1981). Pharmacology of nadolol. In E. F. Gross (Ed.) International experience with nadolol, a long-acting β-blocking agent, pp. 11-24. Academic Press: New York.
3. Berry, W. D., Murphy, J. D., Smith, B. A., Taylor, G. R., & Sonnenfeld, G. (1991). Effect of microgravity modeling on interferon and interleukin responses in the rat. J. Interferon Res. 11, 243-249.
4. Byron, J. W. (1972). Evidence for a β-adrenergic receptor initiating DNA synthesis in haemopoietic stem cell. Exp. Cell Res. 71, 228-232.
5. Chou, S. H., Kojic, L. D., Nordyke-Messingham, K., & Cunnick, J. E. (1996). Characterization of the effect of 2-deoxy-D-glucose (2-DG) on the immune system. Brain. Behav. Immun. 10, 399-416.
6. Cunnick, J. E., Lysle, D. T., Kucinski, B. J., & Rabin, B. S. (1990). Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral β-adrenergic receptor. Pharmacol. Biochem. Behav. 36, 645-651.
7. Cupps, T. R., & Fauci, A. S. (1982). Corticosterone-mediated immunoregulation in man. Immunol. Rev. 65, 133-155.
8. Dhabhar, F. S., Miller, A. H., Stein, M., McEwen, B. S., & Spencer, R. L. (1995). Effect of stress on immune cell distribution: Dynamics and hormonal mechanisms. J. Immunol. 1554, 5511-5527.
9. Fecho, K., Dykstra, L. A., & Lysle, D. T. (1993). Evidence for β-adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265(3), 1079-1087.
10. Fecho, K., Maslonek, K. A., Coussons-Read, M. E., Dykstra, L. A., & Lysle, D. T. (1994). Macrophage-derived nitric oxide is involved in depressed Concanavaline A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152, 5845-5852.
11. Felten, D. L., Felten, S. Y., Carlson, S. L., Olschowka, J. A., & Livnat, S. (1985). Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135, suppl., 755s-765s.
12. Felten, D. L., & Olschowka, J. A. (1987). Noradrenergic sympathetic innervation of the spleen. II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18, 37-48.
13. Fuchs, B. A., Campbell, K. S., & Munson, A. E. (1988). Norepinephrine and serotonin content of the murine spleen: Its relationship to lymphocyte β-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell. Immunol. 117, 339-351.
14. Galant, S. P., Durisetti, L., Underwood, S., & Insel, P. A. (1978). Beta adrenergic receptors on polymorphonuclear leukocytes: Adrenergic therapy decreases receptor number. N. Engl. J. Med. 299, 933-936.
15. Irwin, M., Brown, M., Patterson, T., Hauger, R., Mascovich, A., & Grant, I. (1991). Neuropeptide Y and natural killer cell activity: Findings in depression and Alzheimer caregiver stress. FASEB J. 5, 3100-3107.
16. Johnson, H. M., Dianzani, F., & Georgiades, J. A. (1981). Large-scale induction and production of human and mouse immune interferons. In Methods in enzymology, Vol. 78, pp. 158-162. Academic Press: New York.
17. Kelso, A., & Munck, A. (1984). Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J. Immunol. 133, 784-791.
18. Lysle, D. T., Cunnick, J. E., Wu, R., Caggiula, A. R., Wood, P., & Rabin, B. S. (1988). 2-deoxy-D-glucose modulation of T-lymphocyte reactivity: Differential effects on lymphoid compartments. Brain Behav. Immun. 2, 212-221.
19. Lysle, D. T., Cunnick, J. E., Kucinski, B. J., Fowler, H., & Rabin, B. S. (1990). Characterization of immune alterations induced by a conditioned aversive stimulus. Psychobiology 18, 220-226.
20. Lysle, D. T., Fecho, K., Maslonek, K. A., & Dykstra, L. A. (1995). Evidence for the involvement of macrophage-derived nitric oxide in the immunomodulatory effect of morphine and aversive Pavlovian conditioning. Adv. Exp. Med. Biol. 373, 141-147.
21. Luecken, L. J., & Lysle, D. T. (1992). Evidence for the involvement of β-adrenergic receptors in conditioned immunomodulation. J. Neuroimmunol. 38, 209-220.
22. Madden, K. S., & Livnat, S. (1991). Catecholamine action and immunologic reactivity. In R. Ader, D. L. Felten, & N. Cohen (Eds.), Psychoneuroimmunology, 2nd ed. pp. 283-310, Academic Press: San Diego.
23. Madden, K. S., & Felten, D. L. (1995). Experimental basis for neural-immune interactions. Physiol. Rev. 75, 77-106.
24. Michl, J., Ohlbaum, D. J., & Silverstein, S. C. (1976). 2-deoxyglucose selectively inhibits Fc and Complement receptor-mediated phagocytosis in mouse peritoneal macrophages. II. Dissociation of the inhibitory effects of 2-deoxyglucose on phagocytosis and ATP generation. J. Exp. Med. 144, 1484-1493.
25. Miller, E. S., Klinger, J. C., Akin, C., Koebel, D. A., & Sonnenfeld, G. (1994). Inhibition of murine splenic T lymphocyte proliferation by 2-deoxy-D-glucose-induced metabolic stress. J. Neuroimmunol. 52, 165-173.
26. Mills, C. D. (1991). Molecular basis of "suppressor" macrophages arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146(8), 2719-2723.
27. Murphy, B. E. (1967). Some studies on the protein binding of steroids and their application to the routine micro and ultra-micro measurement of various steroids in body fluids by competitive protein-binding radio-assay. J. Clin. Endocrinol. Metab. 27, 973-990.
28. Pascoe, W. S., Smythe, G. A., & Storlien, L. H. (1989). 2-deoxy-D-glucose-induced hyperglycemia: Role for direct sympathetic nervous system activation of liver glucose output. Brain Res. 505, 23-28.
29. Press, H. F., & Maroun, J. A. (1984). The standardization of NK cell assays for use in studies of biological response modifiers. J. Immunol. Methods 68, 235-249.
30. Ritter, R. C., & Neville, M. (1976). Hypothalamic noradrenaline turnover is increased during glucoprivic feeding. Fed. Proc. 35, 642.
31. Rose, A., Steffen, J. M., Musacchia, X. J., Mandel, A. D., & Sonnenfeld, G. (1984). Effect of antiorthostatic suspension on interferon-α/β production by the mouse. Proc. Soc. Exp. Biol. Med. 177, 254-256.
32. Smith, G. P., & Root, A. W. (1969). Effects of feeding on hormonal responses to 2-deoxy-D-glucose in conscious monkeys. Endocrinology 85, 963-966.
33. Shavit, Y., Lewis, J. W., Terman, G. W., Gale, R. P., & Liebeskind, J. C. (1984). Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223, 188-190.
34. Sonnenfeld, G., Cunnick, J. E., Armfield, A. V., Wood, P. G., & Rabin, B. S. (1992). Stress-induced alterations in interferon production and Class II histocompatibility antigen expression. Brain Behav. Immun. 6, 170-178.
35. Stuehr, D. J., & Nathan, C. F. (1989). Nitric oxide: A macrophage product responsible for cytosis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543-1555.
36. 3H-alprenolol binding. J. Clin. Invest. 57, 149-155.